Director of Substance Use Research
Infectious Disease
Dr. Phillip O. Coffin, MD
Dr. Phillip O. Coffin practices Infectious Disease. He attended University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. Phillip Coffin is also published. He has 33 publications published. The lastest publication: "Commentary on Pierce et al. (2016): Raising the bar of addiction treatment-first do no harm.' Phillip Coffin accepts Medicare.
Publications
- Commentary on Pierce et al. (2016): Raising the bar of addiction treatment-first do no harm.
- Novel Interventions to Prevent HIV and HCV Among Persons Who Inject Drugs.
- Brief overdose education is sufficient for naloxone distribution to opioid users.
- Trends in use of health care and HIV prevention services for persons who inject drugs in San Francisco: Results from National HIV Behavioral Surveillance 2005-2012.
- Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.
- Substance use and drinking outcomes in Personalized Cognitive Counseling randomized trial for episodic substance-using men who have sex with men.
- Adapted Personalized Cognitive Counseling for Episodic Substance-Using Men Who Have Sex with Men: A Randomized Controlled Trial.
- Police Officers' and Paramedics' Experiences with Overdose and Their Knowledge and Opinions of Washington State's Drug Overdose-Naloxone-Good Samaritan Law.
- Dose-response associations between number and frequency of substance use and high-risk sexual behaviors among HIV-negative substance-using men who have sex with men (S...
- Aripiprazole for the treatment of methamphetamine dependence: A randomized, double-blind, placebo-controlled trial.
- "Hooked on" prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients.
- Patient acceptance of universal screening for hepatitis C virus infection.
- Risk factors for nonfatal overdose at Seattle-area syringe exchanges.
- The interface between substance abuse and chronic pain management in primary care: a curriculum for medical residents.
- Identifying injection drug users at risk of nonfatal overdose.
- Cause of death in alcoholic hepatitis.
- Support for buprenorphine and methadone prescription to heroin-dependent patients among New York City physicians.
- Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose.
- Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City.
- Drug overdose: new insights, innovative surveillance, and promising interventions.
- Racial/ethnic disparities in overdose mortality trends in New York City, 1990-1998.
- Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City.
- More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users.
- Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.
- Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal.
- Integrating HIV risk reduction into the medical curriculum.
- A vulnerable population in a time of crisis: drug users and the attacks on the World Trade Center.
- Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98.
- Income distribution and risk of fatal drug overdose in New York City neighborhoods.
- Balancing the costs and benefits of opioid analgesics in the United States.
- Circumstances of witnessed drug overdose in New York City: implications for intervention.
- Safe syringe disposal is related to safe syringe access among HIV-positive injection drug users.
Schools
University Of California San Francisco School Of Medicine
Columbia Unviersity Medical Center
University of Washington
Brown University
Columbia University School Of International and Public Affairs
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
University of Washington -
New York Presbyterian Hospital - Columbia Campus -
University of California San Francisco School of Medicine
Drug Facts
| NPI NUMBER | 1265616296 | |
| NPPES Provider LastName | COFFIN | |
| NPPES Provider FirstName | PHILLIP | |
| NPPES Provider ZIPCode | 981012756 | |
| NPPES Provider State | WA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 57.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265616296 |
| Last Name Of The Provider | COFFIN |
| First Name Of The Provider | PHILLIP |
| View All |
Similar Doctors
|
Dr. Joseph M. McCune III, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Shelley M. Gordon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph K. Wong, MD |
|
|
Dr. David F. Busch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie L. Gerberding, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Richard M. Locksley, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Uri A. Lopatin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip Rosenthal, MD |
|
|
Dr. Juliet E. Stoltey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc M. Solomon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lowell S. Young, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie M. Higashi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip J. Rosenthal, MD |
|
|
Dr. Brinda Emu, MD
This Doctor is OpenDoctor Recommended.
|